Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S16 pseudogene 3 (RPS16P3) is a processed pseudogene derived from the ribosomal protein S16 gene. Pseudogenes are non-functional sequences in the genome that resemble known genes but lack the ability to code for a protein, often due to accumulated mutations or the absence of regulatory elements needed for expression. RPS16P3 does not encode a functional protein and does not participate in canonical biological or disease pathways. Its presence in the genome is typical for genes encoding ribosomal proteins, as these often have multiple processed pseudogenes dispersed throughout the genome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S16 pseudogene 3 (RPS16P3).